DOCSLIB.ORG

Interactions Between Mammalian WDR12 and Midasin the Crystal

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Interactions Between Mammalian WDR12 and Midasin the Crystal JBC Papers in Press. Published on November 24, 2015 as Manuscript M115.693259 The latest version is at http://www.jbc.org/cgi/doi/10.1074/jbc.M115.693259 Interactions between mammalian WDR12 and Midasin The Crystal Structure of the Ubiquitin-Like Domain of Ribosome Assembly Factor Ytm1 and Characterization of its Interaction with the AAA-ATPase Midasin Erin M. Romes, Mack Sobhany, and Robin E. Stanley* From the Signal Transduction Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, 111 T. W. Alexander Drive, Research Triangle Park, North Carolina 27709, USA Running Title: Interactions between mammalian WDR12 and Midasin *To whom correspondence should be addressed: Robin E. Stanley, Ph.D, Signal Transduction Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health Building 101, Room F378, 111 T. W. Alexander Drive, Research Triangle Park, NC 27709, Telephone: (919)541-0270; E-mail: [email protected] Downloaded from Keywords: ribosome assembly, rRNA processing, crystallography, ATPases associated with diverse cellular activities (AAA), metal ion‐protein interaction http://www.jbc.org/ ABSTRACT and the interaction is dependent upon metal The synthesis of eukaryotic ribosomes ion-coordination as removal of the metal or is a complex, energetically-demanding process mutation of residues that coordinate the metal requiring the aid of numerous non-ribosomal ion diminishes the interaction. Mammalian factors such as the PeBoW complex. The WDR12 displays prominent nucleolar by guest on April 26, 2017 mammalian PeBoW complex, comprised of localization that is dependent upon active Pes1, Bop1, and WDR12, is essential for the rRNA transcription. Based upon these results processing of the 32S pre-ribosomal RNA. we propose that release of the PeBoW Previous work in Saccharomyces cerevisiae complex and subsequent release of Nle1 by has shown that release of the homologous Midasin is a well-conserved step in the proteins in this complex (Nop7, Erb1, and ribosome maturation pathway in both yeast Ytm1, respectively) from pre-ribosomal and mammalian cells. particles requires Rea1 (Midasin or MDN1 in _____________________________________ humans), a large dynein-like protein. Midasin Ribosomes are large macromolecular contains a C-terminal metal ion-dependent machines comprised of four pieces of adhesion site (MIDAS) domain that interacts ribosomal RNA (rRNA) and 80 (79 in yeast) with the N-terminal ubiquitin-like (UBL) associated ribosomal proteins (1,2). domain of Ytm1/WDR12 as well as the UBL Ribosomes are responsible for carrying out the domain of Rsa4/Nle1 in a later step in the synthesis of all proteins within a cell, and the ribosome maturation pathway. Here we eukaryotic ribosome is composed of two present the crystal structure of the UBL subunits known as the small subunit (40S) and domain of the WDR12 homologue from S. the large subunit (60S). The assembly of cerevisiae at 1.7 Å resolution and demonstrate ribosomes begins in the nucleolus with the that human Midasin binds to WDR12 as well transcription of the rRNAs. Three of the as Nle1 through their respective UBL rRNAs are transcribed as a single poly- domains. Midasin contains a well-conserved cistronic precursor (18S, 5.8S, and 25S), extension region upstream of the MIDAS which must then be modified, folded, domain required for binding WDR12 and Nle1 processed and exported to the cytoplasm in a 1 Copyright 2015 by The American Society for Biochemistry and Molecular Biology, Inc. Interactions between mammalian WDR12 and Midasin carefully orchestrated manor (3,4). Ribosome in yeast, Nop7, Erb1, and Ytm1 are all biogenesis in eukaryotic cells is an incredibly essential proteins required for the processing complex and energetically demanding process of the 27SA3 pre-rRNA (17,18). All that requires more than 200 essential non- components of the PeBoW/Nop7 complex are ribosomal assembly factors (3-6). thought to be multifunctional proteins and Defects in the mammalian ribosome have been linked with roles in various cellular biogenesis pathway are linked to a group of processes including DNA replication, cell human diseases that are collectively called cycle regulation and cardiac function in ribosomopathies. These are all congenital, addition to ribosome biogenesis (19,20). The inherited disorders with a broad clinical PeBoW/Nop7 complex is thought to primarily spectrum that have perplexed researchers for localize to the nucleolus. The complex is not years because they cause tissue-specific found on ribosomal particles within the effects even though ribosomes are essential in nucleoplasm or cytoplasm, indicating that the all cell types (7). Ribosome biogenesis has PeBoW complex must be released from pre- also been emerging as a new target for cancer ribosomal particles prior to their transport out therapy. Recent studies have shown that of the nucleolus (16,18,21). several important oncogenes, including One way in which ribosome cMYC, RAS and PI3K, play key roles in maturation factors are released from pre- Downloaded from promoting hyperactive ribosome biogenesis, ribosome particles is through the aid of three and deregulated ribosomal DNA transcription different AAA-ATPases, Rea1/Midasin, Rix7, is a requirement for the transformed and Drg1/Afg2, which all utilize both phenotype (8). Moreover, studies have also nucleotide binding and hydrolysis to drive http://www.jbc.org/ shown that the nucleolus is a key element in release of distinct ribosome maturation factors regulating the cellular stress response and is (reviewed in (22)). Rea1 is responsible for directly involved in regulating the activity of driving release of both the Nop7 complex and the tumor-suppressor p53 in response to stress the maturation factor Rsa4 from pre-60S (9-13). Furthering our understanding of the particles in S. cerevisiae. Rea1 is the largest by guest on April 26, 2017 ribosome biogenesis pathway is essential for protein in S. cerevisiae and contains an N- the development of new cancer therapeutics terminal domain, six concatenated ATPase and treatments for ribosomopathies. domains, a 260kDa linker domain, and a C- The majority of what is known about terminal MIDAS domain that is well eukaryotic ribosome biogenesis is based on conserved across all eukaryotes (23). Electron extensive studies in the budding yeast S. microscopy studies reveal that Rea1 has a cerevisiae (recently reviewed in (4)). While large AAA motor domain connected to a the overall process is thought to be well flexible tail-like structure, which contains the conserved among eukaryotes, much less is MIDAS domain at the end (24). Electron known about ribosome biogenesis in higher microscopy studies also indicate that Rea1 organisms (14). One complex that has been contacts pre-ribosome particles adjacent to the well characterized in both yeast and Rix1-Ipi1-Ipi3 subcomplex with the tail being mammalian cells is the PeBoW complex able to reach the pre-ribosomal factor Rsa4 (Nop7 complex in S. cerevisiae). The PeBoW (24). Further studies in S. cerevisiae complex was named for the mammalian demonstrated that Rea1 and Rsa4 interact with assembly proteins Pes1 (Pescadillo), Bop1 one another in vivo and in vitro through the (block of proliferation), and WDR12 (WD MIDAS domain of Rea1 and the conserved N- repeat domain 12), while the yeast terminal UBL domain of Rsa4, which was homologues are Nop7, Erb1, and Ytm1 previously referred to as the MIDO (MIDAS respectively. Knockdown of any of the interacting) domain (24). Interaction between proteins within the mammalian PeBoW Rea1 and Rsa4 coupled with ATP hydrolysis complex blocks processing of the large triggers release of Rsa4 from pre-ribosomal subunit 32S pre-RNA and triggers p53- particles, likely through a large-scale dependent cell cycle arrest (15,16). Similarly mechanical conformational change (22,24). 2 Interactions between mammalian WDR12 and Midasin The mammalian homologue of Rsa4 is called structural information for WDR12, and Notchless (Nle1) and was so named because it suggest that interactions between Midasin with is a direct regulator of the Notch signaling the UBL domains of WDR12 and Nle1 are pathway in Drosophila melanogaster in important evolutionarily conserved addition to its role in ribosome maturation interactions in the ribosome assembly (25). pathway. In addition to driving release of Rsa4, Rea1 has also been shown to drive release of EXPERIMENTAL PROCEDURES the Nop7 complex from nucleolar pre- ribosome particles in S. cerevisiae. Reagents – Normal rabbit IgG Bioinformatic analysis revealed that the N- antibodies against Midasin and WDR12 for terminal UBL domain of Rsa4 is homologous use in immunohistochemistry were obtained to the N-terminal UBL domain of Ytm1, from Sigma Life Science. Normal mouse suggesting that Rea1 could interact with Ytm1 antibodies conjugated with horseradish through its MIDAS domain (21). Earlier work peroxidase against GST (B-14) and His (H3) in mice also suggested that the N-terminal for use in Western Blots were obtained from domain of WDR12 showed similarity to the Santa Cruz Biotechnology. Monoclonal N-terminal domain of Nle1, and it was mouse antibody against the Strep-Tag peptide Downloaded from originally referred to in the literature as the and normal rabbit antibody against Actin for Nle1 domain (26). Subsequent experiments in use as primary antibodies in Western Blots S. cerevisiae demonstrated that Ytm1 interacts
Load more

Recommended publications
  • A Genome-Wide Association Study of a Coronary Artery Disease Risk Variant
    Journal of Human Genetics (2013) 58, 120–126 & 2013 The Japan Society of Human Genetics All rights reserved 1434-5161/13 www.nature.com/jhg ORIGINAL ARTICLE A genome-wide association study of a coronary artery diseaseriskvariant Ji-Young Lee1,16, Bok-Soo Lee2,16, Dong-Jik Shin3,16, Kyung Woo Park4,16, Young-Ah Shin1, Kwang Joong Kim1, Lyong Heo1, Ji Young Lee1, Yun Kyoung Kim1, Young Jin Kim1, Chang Bum Hong1, Sang-Hak Lee3, Dankyu Yoon5, Hyo Jung Ku2, Il-Young Oh4, Bong-Jo Kim1, Juyoung Lee1, Seon-Joo Park1, Jimin Kim1, Hye-kyung Kawk1, Jong-Eun Lee6, Hye-kyung Park1, Jae-Eun Lee1, Hye-young Nam1, Hyun-young Park7, Chol Shin8, Mitsuhiro Yokota9, Hiroyuki Asano10, Masahiro Nakatochi11, Tatsuaki Matsubara12, Hidetoshi Kitajima13, Ken Yamamoto13, Hyung-Lae Kim14, Bok-Ghee Han1, Myeong-Chan Cho15, Yangsoo Jang3,17, Hyo-Soo Kim4,17, Jeong Euy Park2,17 and Jong-Young Lee1,17 Although over 30 common genetic susceptibility loci have been identified to be independently associated with coronary artery disease (CAD) risk through genome-wide association studies (GWAS), genetic risk variants reported to date explain only a small fraction of heritability. To identify novel susceptibility variants for CAD and confirm those previously identified in European population, GWAS and a replication study were performed in the Koreans and Japanese. In the discovery stage, we genotyped 2123 cases and 3591 controls with 521 786 SNPs using the Affymetrix SNP Array 6.0 chips in Korean. In the replication, direct genotyping was performed using 3052 cases and 4976 controls from the KItaNagoya Genome study of Japan with 14 selected SNPs.
    [Show full text]
  • UNIVERSITY of CALIFORNIA, SAN DIEGO Functional Analysis of Sall4
    UNIVERSITY OF CALIFORNIA, SAN DIEGO Functional analysis of Sall4 in modulating embryonic stem cell fate A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Molecular Pathology by Pei Jen A. Lee Committee in charge: Professor Steven Briggs, Chair Professor Geoff Rosenfeld, Co-Chair Professor Alexander Hoffmann Professor Randall Johnson Professor Mark Mercola 2009 Copyright Pei Jen A. Lee, 2009 All rights reserved. The dissertation of Pei Jen A. Lee is approved, and it is acceptable in quality and form for publication on microfilm and electronically: ______________________________________________________________ ______________________________________________________________ ______________________________________________________________ ______________________________________________________________ Co-Chair ______________________________________________________________ Chair University of California, San Diego 2009 iii Dedicated to my parents, my brother ,and my husband for their love and support iv Table of Contents Signature Page……………………………………………………………………….…iii Dedication…...…………………………………………………………………………..iv Table of Contents……………………………………………………………………….v List of Figures…………………………………………………………………………...vi List of Tables………………………………………………….………………………...ix Curriculum vitae…………………………………………………………………………x Acknowledgement………………………………………………….……….……..…...xi Abstract………………………………………………………………..…………….....xiii Chapter 1 Introduction ..…………………………………………………………………………….1 Chapter 2 Materials and Methods……………………………………………………………..…12
    [Show full text]
  • Noelia Díaz Blanco
    Effects of environmental factors on the gonadal transcriptome of European sea bass (Dicentrarchus labrax), juvenile growth and sex ratios Noelia Díaz Blanco Ph.D. thesis 2014 Submitted in partial fulfillment of the requirements for the Ph.D. degree from the Universitat Pompeu Fabra (UPF). This work has been carried out at the Group of Biology of Reproduction (GBR), at the Department of Renewable Marine Resources of the Institute of Marine Sciences (ICM-CSIC). Thesis supervisor: Dr. Francesc Piferrer Professor d’Investigació Institut de Ciències del Mar (ICM-CSIC) i ii A mis padres A Xavi iii iv Acknowledgements This thesis has been made possible by the support of many people who in one way or another, many times unknowingly, gave me the strength to overcome this "long and winding road". First of all, I would like to thank my supervisor, Dr. Francesc Piferrer, for his patience, guidance and wise advice throughout all this Ph.D. experience. But above all, for the trust he placed on me almost seven years ago when he offered me the opportunity to be part of his team. Thanks also for teaching me how to question always everything, for sharing with me your enthusiasm for science and for giving me the opportunity of learning from you by participating in many projects, collaborations and scientific meetings. I am also thankful to my colleagues (former and present Group of Biology of Reproduction members) for your support and encouragement throughout this journey. To the “exGBRs”, thanks for helping me with my first steps into this world. Working as an undergrad with you Dr.
    [Show full text]
  • The Tumor Suppressor Notch Inhibits Head and Neck Squamous Cell
    The Texas Medical Center Library DigitalCommons@TMC The University of Texas MD Anderson Cancer Center UTHealth Graduate School of The University of Texas MD Anderson Cancer Biomedical Sciences Dissertations and Theses Center UTHealth Graduate School of (Open Access) Biomedical Sciences 12-2015 THE TUMOR SUPPRESSOR NOTCH INHIBITS HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) TUMOR GROWTH AND PROGRESSION BY MODULATING PROTO-ONCOGENES AXL AND CTNNAL1 (α-CATULIN) Shhyam Moorthy Shhyam Moorthy Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations Part of the Biochemistry, Biophysics, and Structural Biology Commons, Cancer Biology Commons, Cell Biology Commons, and the Medicine and Health Sciences Commons Recommended Citation Moorthy, Shhyam and Moorthy, Shhyam, "THE TUMOR SUPPRESSOR NOTCH INHIBITS HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) TUMOR GROWTH AND PROGRESSION BY MODULATING PROTO-ONCOGENES AXL AND CTNNAL1 (α-CATULIN)" (2015). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access). 638. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/638 This Dissertation (PhD) is brought to you for free and open access by the The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at DigitalCommons@TMC. It has been accepted for inclusion in The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access) by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. THE TUMOR SUPPRESSOR NOTCH INHIBITS HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) TUMOR GROWTH AND PROGRESSION BY MODULATING PROTO-ONCOGENES AXL AND CTNNAL1 (α-CATULIN) by Shhyam Moorthy, B.S.
    [Show full text]
  • 1 Mutational Heterogeneity in Cancer Akash Kumar a Dissertation
    Mutational Heterogeneity in Cancer Akash Kumar A dissertation Submitted in partial fulfillment of requirements for the degree of Doctor of Philosophy University of Washington 2014 June 5 Reading Committee: Jay Shendure Pete Nelson Mary Claire King Program Authorized to Offer Degree: Genome Sciences 1 University of Washington ABSTRACT Mutational Heterogeneity in Cancer Akash Kumar Chair of the Supervisory Committee: Associate Professor Jay Shendure Department of Genome Sciences Somatic mutation plays a key role in the formation and progression of cancer. Differences in mutation patterns likely explain much of the heterogeneity seen in prognosis and treatment response among patients. Recent advances in massively parallel sequencing have greatly expanded our capability to investigate somatic mutation. Genomic profiling of tumor biopsies could guide the administration of targeted therapeutics on the basis of the tumor’s collection of mutations. Central to the success of this approach is the general applicability of targeted therapies to a patient’s entire tumor burden. This requires a better understanding of the genomic heterogeneity present both within individual tumors (intratumoral) and amongst tumors from the same patient (intrapatient). My dissertation is broadly organized around investigating mutational heterogeneity in cancer. Three projects are discussed in detail: analysis of (1) interpatient and (2) intrapatient heterogeneity in men with disseminated prostate cancer, and (3) investigation of regional intratumoral heterogeneity in
    [Show full text]
  • Genome-Wide Association Studies of Retinal Vessel Tortuosity Identify 173
    medRxiv preprint doi: https://doi.org/10.1101/2020.06.25.20139725; this version posted March 24, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license . Genome-Wide Association Studies of retinal vessel tortuosity identify 173 novel loci, capturing genes and pathways associated with disease and vascular tissue pathomechanics Mattia Tomasoni1,2, Michael Johannes Beyeler1,2, Ninon Mounier2,3, Eleonora Porcu2,3,4, Sofia Ortin Vela1,2, Alexander Luke Button1,2, Tanguy Corre1,2,3, Hana Abouzeid5,6, Murielle Bochud3, Daniel Krefl1,2, Sven Bergmann1,2,7 1 Dept. of Computational Biology, University of Lausanne, Lausanne, Switzerland 2 Swiss Institute of Bioinformatics, Lausanne, Switzerland 3 Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland 4 Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland 5 Division of Ophthalmology, Geneva University Hospitals, Switzerland 6 Clinical Eye Research Center Memorial Adolphe de Rothschild, Geneva, Switzerland 7 Dept. of Integrative Biomedical Sciences, University of Cape Town, Cape Town, South Africa Corresponding authors: [email protected] [email protected] Abstract Fundus images of the eye allow for non-invasive inspection of the microvasculature system of the retina, which is informative of systemic cardiovascular health. We set up a fully automated image processing pipeline enabling the massively parallelised annotation of such images in terms of vessel type (i.e., artery or vein) and quantitative morphological properties, such as tortuosity (“bendiness”).
    [Show full text]
  • Identification of Genetic Factors Underpinning Phenotypic Heterogeneity in Huntington’S Disease and Other Neurodegenerative Disorders
    Identification of genetic factors underpinning phenotypic heterogeneity in Huntington’s disease and other neurodegenerative disorders. By Dr Davina J Hensman Moss A thesis submitted to University College London for the degree of Doctor of Philosophy Department of Neurodegenerative Disease Institute of Neurology University College London (UCL) 2020 1 I, Davina Hensman Moss confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis. Collaborative work is also indicated in this thesis. Signature: Date: 2 Abstract Neurodegenerative diseases including Huntington’s disease (HD), the spinocerebellar ataxias and C9orf72 associated Amyotrophic Lateral Sclerosis / Frontotemporal dementia (ALS/FTD) do not present and progress in the same way in all patients. Instead there is phenotypic variability in age at onset, progression and symptoms. Understanding this variability is not only clinically valuable, but identification of the genetic factors underpinning this variability has the potential to highlight genes and pathways which may be amenable to therapeutic manipulation, hence help find drugs for these devastating and currently incurable diseases. Identification of genetic modifiers of neurodegenerative diseases is the overarching aim of this thesis. To identify genetic variants which modify disease progression it is first necessary to have a detailed characterization of the disease and its trajectory over time. In this thesis clinical data from the TRACK-HD studies, for which I collected data as a clinical fellow, was used to study disease progression over time in HD, and give subjects a progression score for subsequent analysis. In this thesis I show blood transcriptomic signatures of HD status and stage which parallel HD brain and overlap with Alzheimer’s disease brain.
    [Show full text]
  • Alisertib Induces Cell Cycle Arrest, Apoptosis, Autophagy and Suppresses EMT in HT29 and Caco-2 Cells
    Article Alisertib Induces Cell Cycle Arrest, Apoptosis, Autophagy and Suppresses EMT in HT29 and Caco-2 Cells Bao-Jun Ren 1,2, Zhi-Wei Zhou 2, Da-Jian Zhu 1, Yong-Le Ju 1, Jin-Hao Wu 1, Man-Zhao Ouyang 1, Xiao-Wu Chen 1,* and Shu-Feng Zhou 2,* Received: 2 November 2015; Accepted: 9 December 2015; Published: 29 December 2015 Academic Editor: William Chi-shing Cho 1 Department of Gastrointestinal Surgery, Shunde First People’s Hospital Affiliated to Southern Medical University, Guangdong 528300, China; [email protected] (B.-J.R.); [email protected] (D.-J.Z.); [email protected] (Y.-L.J.); [email protected] (J.-H.W.); [email protected] (M.-Z.O.) 2 Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, 12901 Bruce B. Downs Blvd., MDC 30, Tampa, FL 33612, USA; [email protected] * Correspondence: [email protected] (X.-W.C.); [email protected] (S.-F.Z.); Tel.: +86-757-2231-8555 (X.-W.C.); +1-813-974-6276 (S.-F.Z.); Fax: +86-757-2222-3899 (X.-W.C.); +1-813-905-9885 (S.-F.Z.) Abstract: Colorectal cancer (CRC) is one of the most common malignancies worldwide with substantial mortality and morbidity. Alisertib (ALS) is a selective Aurora kinase A (AURKA) inhibitor with unclear effect and molecular interactome on CRC. This study aimed to evaluate the molecular interactome and anticancer effect of ALS and explore the underlying mechanisms in HT29 and Caco-2 cells. ALS markedly arrested cells in G2/M phase in both cell lines, accompanied by remarkable alterations in the expression level of key cell cycle regulators.
    [Show full text]
  • Forms of Supplemental Selenium in Vitamin-Mineral
    University of Kentucky UKnowledge Theses and Dissertations--Animal and Food Sciences Animal and Food Sciences 2019 FORMS OF SUPPLEMENTAL SELENIUM IN VITAMIN-MINERAL MIXES DIFFERENTIALLY AFFECT SEROLOGICAL AND HEPATIC PARAMETERS OF GROWING BEEF STEERS GRAZING ENDOPHYTE-INFECTED TALL FESCUE Yang Jia University of Kentucky, [email protected] Digital Object Identifier: https://doi.org/10.13023/etd.2019.028 Right click to open a feedback form in a new tab to let us know how this document benefits ou.y Recommended Citation Jia, Yang, "FORMS OF SUPPLEMENTAL SELENIUM IN VITAMIN-MINERAL MIXES DIFFERENTIALLY AFFECT SEROLOGICAL AND HEPATIC PARAMETERS OF GROWING BEEF STEERS GRAZING ENDOPHYTE- INFECTED TALL FESCUE" (2019). Theses and Dissertations--Animal and Food Sciences. 97. https://uknowledge.uky.edu/animalsci_etds/97 This Doctoral Dissertation is brought to you for free and open access by the Animal and Food Sciences at UKnowledge. It has been accepted for inclusion in Theses and Dissertations--Animal and Food Sciences by an authorized administrator of UKnowledge. For more information, please contact [email protected]. STUDENT AGREEMENT: I represent that my thesis or dissertation and abstract are my original work. Proper attribution has been given to all outside sources. I understand that I am solely responsible for obtaining any needed copyright permissions. I have obtained needed written permission statement(s) from the owner(s) of each third-party copyrighted matter to be included in my work, allowing electronic distribution (if such use is not permitted by the fair use doctrine) which will be submitted to UKnowledge as Additional File. I hereby grant to The University of Kentucky and its agents the irrevocable, non-exclusive, and royalty-free license to archive and make accessible my work in whole or in part in all forms of media, now or hereafter known.
    [Show full text]
  • A SARS-Cov-2 Protein Interaction Map Reveals Targets for Drug Repurposing
    Article A SARS-CoV-2 protein interaction map reveals targets for drug repurposing https://doi.org/10.1038/s41586-020-2286-9 A list of authors and affiliations appears at the end of the paper Received: 23 March 2020 Accepted: 22 April 2020 A newly described coronavirus named severe acute respiratory syndrome Published online: 30 April 2020 coronavirus 2 (SARS-CoV-2), which is the causative agent of coronavirus disease 2019 (COVID-19), has infected over 2.3 million people, led to the death of more than Check for updates 160,000 individuals and caused worldwide social and economic disruption1,2. There are no antiviral drugs with proven clinical efcacy for the treatment of COVID-19, nor are there any vaccines that prevent infection with SARS-CoV-2, and eforts to develop drugs and vaccines are hampered by the limited knowledge of the molecular details of how SARS-CoV-2 infects cells. Here we cloned, tagged and expressed 26 of the 29 SARS-CoV-2 proteins in human cells and identifed the human proteins that physically associated with each of the SARS-CoV-2 proteins using afnity-purifcation mass spectrometry, identifying 332 high-confdence protein–protein interactions between SARS-CoV-2 and human proteins. Among these, we identify 66 druggable human proteins or host factors targeted by 69 compounds (of which, 29 drugs are approved by the US Food and Drug Administration, 12 are in clinical trials and 28 are preclinical compounds). We screened a subset of these in multiple viral assays and found two sets of pharmacological agents that displayed antiviral activity: inhibitors of mRNA translation and predicted regulators of the sigma-1 and sigma-2 receptors.
    [Show full text]
  • View of Neuwald Et Al [5]
    BMC Genomics BioMed Central Research3 BMC2002, Genomics article x Expression and genomic analysis of midasin, a novel and highly conserved AAA protein distantly related to dynein Joan E Garbarino and I R Gibbons* Address: Molecular and Cell Biology Department, University of California Berkeley, Berkeley CA 94720-3200, USA E-mail: Joan E Garbarino - [email protected]; IR Gibbons* - [email protected] *Corresponding author Published: 8 July 2002 Received: 23 April 2002 Accepted: 8 July 2002 BMC Genomics 2002, 3:18 This article is available from: http://www.biomedcentral.com/1471-2164/3/18 © 2002 Garbarino and Gibbons; licensee BioMed Central Ltd. Verbatim copying and redistribution of this article are permitted in any medium for any pur- pose, provided this notice is preserved along with the article's original URL. Abstract Background: The largest open reading frame in the Saccharomyces genome encodes midasin (MDN1p, YLR106p), an AAA ATPase of 560 kDa that is essential for cell viability. Orthologs of midasin have been identified in the genome projects for Drosophila, Arabidopsis, and Schizosaccharomyces pombe. Results: Midasin is present as a single-copy gene encoding a well-conserved protein of ~600 kDa in all eukaryotes for which data are available. In humans, the gene maps to 6q15 and encodes a predicted protein of 5596 residues (632 kDa). Sequence alignments of midasin from humans, yeast, Giardia and Encephalitozoon indicate that its domain structure comprises an N-terminal domain (35 kDa), followed by an AAA domain containing six tandem AAA protomers (~30 kDa each), a linker domain (260 kDa), an acidic domain (~70 kDa) containing 35–40% aspartate and glutamate, and a carboxy-terminal M-domain (30 kDa) that possesses MIDAS sequence motifs and is homologous to the I-domain of integrins.
    [Show full text]
  • Integrative Genetic and Epigenetic Analysis Uncovers Regulatory
    bioRxiv preprint doi: https://doi.org/10.1101/054361; this version posted May 19, 2016. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 1 Integrative genetic and epigenetic analysis uncovers regulatory 2 mechanisms of autoimmune disease 1;2 2;3 1;2;4;5 3 Parisa Shooshtari , Hailieng Huang , and Chris Cotsapas 4 May 19, 2016 1 5 Department of Neurology, Yale School of Medicine, New Haven CT, USA 2 6 Program in Medical and Population Genetics and Stanley Center for Psychiatric Research, Broad 7 Institute of Harvard and MIT, Cambridge, Massachusetts, USA 3 8 Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hos- 9 pital and Harvard Medical School, Boston, Massachusetts, USA 4 10 Department of Genetics, Yale School of Medicine, New Haven CT, USA 5 11 Correspondence to CC, [email protected] 12 13 Genome-wide association studies in autoimmune and inflammatory diseases (AID) 1,2 14 have uncovered hundreds of loci mediating risk . These associations are preferen- 3,4 15 tially located in non-coding DNA regions and in particular to tissue–specific DNase 5,6 16 I hypersensitivity sites (DHS) . Whilst these analyses clearly demonstrate the over- 17 all enrichment of disease risk alleles on gene regulatory regions, they are not designed 18 to identify individual regulatory regions mediating risk or the genes under their con- 19 trol, and thus uncover the specific molecular events driving disease risk.
    [Show full text]